-+ 0.00%
-+ 0.00%
-+ 0.00%

XTL Biopharmaceuticals Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing

Benzinga·02/27/2026 21:34:31
Listen to the news

According to Nasdaq staff, XTLB qualifies as a "public shell" and does not warrant continued listing of its ADS.